Search results

  1. Utsikt

    Effects of Motor Imagery on Movement-Based Fear in Musculoskeletal Conditions: A Critically Appraised Topic, 2026, Pearcy et al

    That seems like a pretty low bar to get over.. https://pedro.org.au/wp-content/uploads/PEDro_scale.pdf Looks like physios didn’t manage to fix their basic issues with the trial methodology, so they just made an easy version that everyone could pass.
  2. Utsikt

    Demarcation between science and pseudoscience: Still a Problem?

    Some characteristics that are often seen in pseudoscience, but do not by themselves always mean something is pseudoscientific: Ignoring or never seeking out contradictory data Vague and imprecise language Lack of boundaries for what the hypothesis applies to Asserting something that can’t be...
  3. Utsikt

    Medical gaslighting: conceptual and theoretical foundations, 2026, Noble

    People often share things they think might be of interest to others without any personal preferences or opinions.
  4. Utsikt

    Medical gaslighting: conceptual and theoretical foundations, 2026, Noble

    It isn’t that clearcut. The patients can decide that they perceive the impact to be negative, and that they therefore don’t want to go do it, but they don’t have a monopoly on deciding and a doctor shouldn’t give up attempting to persuade them if a reasonable neutral assessment is that impact...
  5. Utsikt

    Trial Report A Continuous Oral Regimen of High-Dose Cromolyn Sodium Is Effective for Some ME/CFS Patients With MCAS, 2026, Christoforou, Rowe et al

    Sure, there might be personal preferences here. I would personally need more than one bottle a day, so this would make me have to carry two or find other ways to get water in addition to the medication bottle. I’m used to pills from other issues before getting ME/CFS and it was never a bother.
  6. Utsikt

    Preprint ME/CFS and Long COVID Demonstrate Similar Bioenergetic Impairment and Recovery Failure on Two-Day Cardiopulmonary Exercise Testing, 2026, Davenport+

    But they have not proved that it’s directly related to PEM, they didn’t even show anything about symptom patterns. So they are either advocating for using an unproven and speculative endpoint, or for using it as a proxy for what’s essentially «overall health and functional capacity», just like...
  7. Utsikt

    Trial Report A Continuous Oral Regimen of High-Dose Cromolyn Sodium Is Effective for Some ME/CFS Patients With MCAS, 2026, Christoforou, Rowe et al

    Thanks for asking! They say that this water bottle regiment increases adherence to the medication regiment. I speculate that the increased adherence is because the participants perceive the higher doses to be beneficial, and not because the water bottle helps the medication work better or be...
  8. Utsikt

    Medical gaslighting: conceptual and theoretical foundations, 2026, Noble

    The patient’s right to refuse any medical treatment without it negatively impacting the other medical care they receive, effectively protects their agency. That mechanism sometimes doesn’t work, but that’s a different question entirely. It is the doctor’s duty to make the best recommendations...
  9. Utsikt

    Trial Report A Continuous Oral Regimen of High-Dose Cromolyn Sodium Is Effective for Some ME/CFS Patients With MCAS, 2026, Christoforou, Rowe et al

    Did they test doing the same high daily doses but four times a day, or did they only test the high doses with water bottles? I suspect a lot of the motivation for adherence might have been based on the perceived benefit and not be related to the method. And some of them took quite a lot of other...
  10. Utsikt

    Preprint ME/CFS and Long COVID Demonstrate Similar Bioenergetic Impairment and Recovery Failure on Two-Day Cardiopulmonary Exercise Testing, 2026, Davenport+

    Why does these findings indicate abnormal aerobic metabolism? VO2 measures how much oxygen your body takes up. If I’ve understood things correctly, that can be affected by uptake (how much the lungs take up), transportation (heart and blood) and utilisation (muscles). Isn’t utilisation the only...
  11. Utsikt

    Systematic analyses of lipid mobilization by human lipid transfer proteins, 2026, Titeca et al

    Systematic analyses of lipid mobilization by human lipid transfer proteins Abstract Line breaks added Lipid transfer proteins (LTPs) maintain the specialized lipid compositions of organellar membranes1,2. In humans, many LTPs are implicated in diseases3, but for the majority, the cargo and...
  12. Utsikt

    Do you have any ideas for topics for PRIME seminars?

    I would love for negative findings to get some more attention. I don’t know if this would be the right place for that, but I think the field might benefit from a broader discussion about where people have looked and found nothing unusual. A call to publish (or at least pre-print or Qeios)...
  13. Utsikt

    Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprine, 2025, Lederman et al.

    A between group difference of 0.6. The MCID for NRS (primary endpoint) is 1-2 for chronic muscoskeletal pain. https://pubmed.ncbi.nlm.nih.gov/15207508/ I can’t find any info about how successful the blinding was.
  14. Utsikt

    Open Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

    The study enrolment page doesn’t contain any info to the patients whatsoever. You have to book a call with someone. https://unhidenow.org/study-enrollment/
  15. Utsikt

    Trial Report Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial, 2025, Goadsby et al

    How feasible is blinding with this drug? I can’t find any data on it. The outcomes were subjective, and if the participants were able to tell if they got the drug or placebo, it might influence their reporting.
  16. Utsikt

    Distinct functional connectivity patterns in [ME/CFS & LC] during cognitive fatigue: a 7 Tesla task-fMRI study, 2026, Inderyas, Marshall-Gradisnik+

    I’d answer «I have no idea because I don’t see any use in speculating in that when I’m so far away from it».
  17. Utsikt

    Episodic memory deficits and processes in post-COVID condition, 2026, Oliver-Mas et al.

    Fig. 1 PCC performance on LASSI-L compared to HC. Figure Legend: FRA1 Free Recall List A Trial 1, CRA 1 Cued Recall List A Trial 1, CRA2Cued Recall List A Trial 2, FRB1 Free Recall List B Trial 1, CRB1 Cued Recall List B Trial 1, CRB2 Cued Recall List B Trial 2, SdFRA Short Delay Free Recall...
  18. Utsikt

    Protocol The effectiveness and acceptability of face-to-face rehabilitation for patients with Long Covid who were not hospitalised…, 2026, Kontou+

    Yet another rehab trial with either subjective outcomes with no blinding or irrelevant objective outcomes that for the most part only measure adherence by proxy. Why not look at potentially useful data like step count, hours worked, wages or other things that might tell us if the patients are...
  19. Utsikt

    Prevalence of Bodily Distress Syndrome and Prediction of Patient Outcomes: Cohort Study of 3762 Individuals With Persistent Pain 2026 Landmark et al

    The first part of the article is about how their data shows that people that have a lot of symptoms have a lot of symptoms, and that people with more symptoms now tend to have more symptoms in the future. The second part is mostly propaganda for mind-body interventions. They don’t give any...
  20. Utsikt

    Protocol Protocol of the digital long COVID study: A single-center, registry-based, feasibility and clinical evaluation study…, 2026, Rohner+

    Open-label and subjective outcomes. What more can you ask for? Shame on you Switzerland and EU: The COI is extensive:
Back
Top Bottom